Statistics for Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).
Total visits
views | |
---|---|
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE). | 26 |
Total visits per month
views | |
---|---|
marzo 2024 | 0 |
abril 2024 | 4 |
mayo 2024 | 0 |
junio 2024 | 0 |
julio 2024 | 0 |
agosto 2024 | 0 |
septiembre 2024 | 0 |
File Visits
views | |
---|---|
PIIS0923753419317594.pdf | 10 |